Taking advantage of an interesting clinical scenario, we want to introduce a discussion about fatality in our daily practice and the need to accept that. An 80 year-old man with non-traumatic spontaneous bleeding tendency came to the clinics. Although being on warfarin as a consequence of primary thrombotic prophylaxis due to an atrial fibrillation, full assessment was performed. Not only the rare entity found on him, but also the severe complication that happened afterwards challenged clinicians and led them to risky treatment options.
An 80 year-old man related the appearance of spontaneous bruising and asthenia several months prior to admission. He described several nontraumatic haematomas, an encapsulated bruise on the back of the hand and no major macroscopic hemorrhages apart from an auto limited conjunctival bleeding. He was on warfarin due to an atrial fibrillation.
Apart from that, physical examination and plain X-rays were unremarkable. Body CT scan revealed a left sided axillary encapsulated hematoma and ruled out active bleeding. Blood cell count was consistent with mild macrocytic anemia (Hb 6'5 g/dL MCV 112'9 fl) and complex clotting abnormalities (Quick Time was 26%, INR 2'95, APTT > 180 seconds and fibrinogen 603 mg/dL). Therefore, warfarin was stopped and clotting factors as well as lupus anticoagulant tested. They came back all normal but for Factor VIII (F VIII), which was below 1%. Antibody Inhibition test was positive (31'5 Bethesda Units) with no presence of interferences with lupus anticoagulant activity and the diagnosis of AHA was achieved. He was started on cyclophosphamide, high doses of oral steroids and recombinant human coagulation Factor VIIa (rFVIIa) replacement therapy with an adequate therapeutic response (Table 1) . However, the patient respiratory condition worsened one month afterwards, and he was admitted to the ward tachypneic, feverish and pancytopenic. After performing a CT scan that showed new bilateral ground-glass infiltrates he developed multi organ failure and died. Retrospectively, he had high ferritin and hypertriglyceridemia. Clinical autopsy found hemophagocytosis on a marrow level as well as bilateral diffuse alveolar damage and cytopathic viral inclusions, positive for CMV with histopathological changes suggestive of bilateral atypical pneumonia.
DISCUSSION
Acquired Hemophilia A (AHA) and hemophagocyticlymphohistiocytosis (HLH) are uncommon conditions with an incidence of less than 5 cases per million population per year [1, 2] . Although rare, they are not exceptional. However, the presence of both of them at the same time is extremely infrequent and may have implications in their prognosis. We present a case of HLH triggered by a CMV infection in a patient previously diagnosed of AHA and treated with immunosuppressant drugs.
Hemophagocyticlymphohistiocytosis (HLH) is an unusual syndrome characterized by fever, splenomegaly, jaundice, and the pathologic finding of hemophagocytosis (phagocytosis by macrophages of erythrocytes, leukocytes, platelets, and their precursors) in the bone marrow and other tissues. Among patients who are clinically stable HLH outcome relies on the treatment of the underlying cause. CMV infection was not suspected on our patient and hence, no antiviral drugs were prescribed. However, among unstable patients, as happened in our case, treatment options are different immunomodulatory drugs [3] . Bearing that in mind, our patient developed a iatrogenic immunocompromised state after receiving cyclophosphamide and steroids which led to the opportunistic pulmonary infection that triggered HLH. Thus, we can say that therapeutic options were also the causes of the problem.
AHA often occurs in the setting of rheumatic diseases, malignancies or several drugs such us penicillin, sulfonamides and phenytoin [4] . The problem centers on the fact that there is a production of anti FVIII antibodies owing to gene polymorphisms (HLA, CTLA 4) and/or autoreactive CD4+ T lymphocytes. 5 As we found none of them in our investigations, the causative condition remains unclear. Diagnosis was challenging at the beginning because the patient was taking warfarin due to a non valvular atrial fibrillation. Nonetheless, despite INR controls within the normal limits, he developed these non-traumatic bruises. We stopped warfarin, checked a complete clotting panel (prolonged APTT and a normal Quick Time) and dosed the clotting factors. Association has not been described yet of these diseases but it is known that both occur within similar diseases such as infections, tumors and autoimmune diseases. Fatality was described by the Greeks as the strong likelihood of ending in disaster. Regarding to medicine, doctors face on their daily basis a strong fight against that. Greeks were highly motivated erudites and scientists that anticipated years ago what will eventually happen to human condition. Taking advantage of case report about a CMV-related HemophagocyticLymphohistiocytosis (HLH) in the setting of an Acquired Hemophilia A (AHA) patient, the authors want to introduce this discussion.
We feel this case was a cascade of fatal events that were not under control and we acted as mere spectators. It was a complex case and, indeed, no big mistakes were committed. We feel we can learn that despite good quality medical care, sometimes no big changes a physician can reflect upon the natural history of a disease. We still wonder whether we should have taken a more conservative approach. The capacity to accept this limitation is the key point to pursue the best for our patients and may help clinicians to take risky pros and cons decisions in the near future.
LEARNING POINTS -The presence of an acquired F VIII inhibitor should be suspected in all patients with nontraumatic bruises or spontaneous hematomas.
-Being the backbone of the treatment replacement therapy and immunosuppressants, we do need to be aware of their potential side effects, such as opportunistic ones.
-An accurate approach to such rare diseases is based on a strong awareness of a self-limited impact as a doctor. Not only a lack of mistakes, but also a broad and sensible mind are some of the pillars of an Internist. 
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